For patients with type 1 diabetes mellitus (T1DM), the greatest prospect for reduced morbidity and insulin independence is the replacement of ?-cells coupled with suppression of the underlying autoimmune process. Since the initially dramatic successes of islet transplantation in achieving this goal with donor islets, significant efforts have been directed at identifying and expanding alternate sources of ?-cells. These efforts have been hampered by several challenges: adult ?-cells are mainly derived by the replication of existing ?-cells, non-?-cells give rise to ?-cells with low efficiency, and the ?-cell phenotype is difficult to achieve or maintain in vitro. In tissues that maintain mass by replication of existing cells, certain forms of injury result in the emergence of a normally quiescent progenitor cell population (""""""""facultative stem cells""""""""). Previous studies have pointed to the presence of such a population in the adult pancreas, but findings have been inconsistent and the precursor population has been elusive. This proposal builds on convincing recent evidence that facultative stem cells reside within the pancreatic ducts and can give rise to large numbers of ?-cells following a specific form of injury: obstruction of the pancreatic duct. This proposal seeks to identify the ductal cells that exhibit this potential, and to develop practical methods for the efficient initiation of duct-to-islet conversion in vitro or in vivo. Specifically, our goal is to stimulate duct- to-islet conversion in rodents with established diabetes as a proof-of-principle for this approach. The proposed studies have the potential for a major impact on the treatment of T1DM by promoting ?-cells neogenesis through the introduction of peptides or small molecules into the pancreatic ductal system.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
NIH Director’s New Innovator Awards (DP2)
Project #
1DP2DK083111-01
Application #
7613726
Study Section
Special Emphasis Panel (ZDK1-GRB-B (O1))
Program Officer
Sato, Sheryl M
Project Start
2008-09-30
Project End
2013-06-30
Budget Start
2008-09-30
Budget End
2013-06-30
Support Year
1
Fiscal Year
2008
Total Cost
$2,362,500
Indirect Cost
Name
University of Pennsylvania
Department
Biology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Spaeth, Jason M; Hunter, Chad S; Bonatakis, Lauren et al. (2015) The FOXP1, FOXP2 and FOXP4 transcription factors are required for islet alpha cell proliferation and function in mice. Diabetologia 58:1836-44
Papageorgiou, Angela; Rapley, Joseph; Mesirov, Jill P et al. (2015) A genome-wide siRNA screen in mammalian cells for regulators of S6 phosphorylation. PLoS One 10:e0116096
Chen, Yi-Ju; Finkbeiner, Stacy R; Weinblatt, Daniel et al. (2014) De novo formation of insulin-producing ""neo-? cell islets"" from intestinal crypts. Cell Rep 6:1046-1058
Gao, Tao; McKenna, Brian; Li, Changhong et al. (2014) Pdx1 maintains ? cell identity and function by repressing an ? cell program. Cell Metab 19:259-71
Wang, Ting; Yanger, Kilangsungla; Stanger, Ben Z et al. (2014) Cytokinesis defines a spatial landmark for hepatocyte polarization and apical lumen formation. J Cell Sci 127:2483-92
Rhim, Andrew D; Oberstein, Paul E; Thomas, Dafydd H et al. (2014) Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. Cancer Cell 25:735-47
Stanger, Ben Z; Hebrok, Matthias (2013) Control of cell identity in pancreas development and regeneration. Gastroenterology 144:1170-9
Pasca di Magliano, Marina; Forsmark, Christopher; Freedman, Steven et al. (2013) Advances in acute and chronic pancreatitis: from development to inflammation and repair. Gastroenterology 144:e1-4
Yi, Chunling; Shen, Zhewei; Stemmer-Rachamimov, Anat et al. (2013) The p130 isoform of angiomotin is required for Yap-mediated hepatic epithelial cell proliferation and tumorigenesis. Sci Signal 6:ra77
Reichert, Maximilian; Takano, Shigetsugu; von Burstin, Johannes et al. (2013) The Prrx1 homeodomain transcription factor plays a central role in pancreatic regeneration and carcinogenesis. Genes Dev 27:288-300

Showing the most recent 10 out of 14 publications